Lung cancer

FILE - In this Sept. 17, 2015 file photo, a smoker holds his cigarette outside Oklahoma County Courthouse in Oklahoma City. A federal health panel wants to widen the number of Americans who get yearly scans for lung cancer, by opening the screening to less-heavy smokers. Lung cancer is the nation's top cancer killer, causing more than 135,000 deaths in the U.S. each year. Smoking is the chief cause and quitting is the best protection. (AP Photo/Sue Ogrocki, File)
July 07, 2020 - 11:02 am
A U.S. health panel wants to widen the number of Americans offered yearly scans for lung cancer by opening the screening to less-heavy smokers. Lung cancer is the nation's top cancer killer, causing more than 135,000 deaths each year. Smoking is the chief cause and quitting the best protection...
Read More
This microscope image made available by the National Cancer Institute Center for Cancer Research in 2015 shows human colon cancer cells with the nuclei stained red. On Friday, May 29, 2020, doctors are reporting success with newer drugs that control certain types of cancer better, reduce the risk it will come back and make treatment simpler and easier to bear. (NCI Center for Cancer Research via AP)
May 29, 2020 - 8:32 am
Doctors are reporting success with newer drugs that control certain types of cancer better, reduce the risk it will come back and make treatment simpler and easier to bear. Gentler drugs would be a relief to patients like Jenn Carroll, a 57-year-old human resources director from New Hartford,...
Read More
February 03, 2020 - 3:27 pm
LOS ANGELES (AP) — Rush Limbaugh says he has advanced lung cancer, tells radio listeners he will miss shows for treatment.
Read More
This 1964 photo made available by the Centers for Disease Control and Prevention shows a lung tissue specimen from a patient with adenocarcinoma of the lung. On Wednesday, Jan. 8, 2020, researchers reported the largest-ever decline in the U.S. cancer death rate, and they are crediting advances in the treatment of lung tumors. Most lung cancer cases are tied to smoking, and decades of declining smoking rates means lower rates of lung cancer diagnoses and deaths. (Dr. Ellis/Emory University, Department of Pathology/CDC via AP)
January 08, 2020 - 7:39 am
NEW YORK (AP) — Researchers on Wednesday reported the largest-ever one-year decline in the U.S. cancer death rate, a drop they credited to advances in lung-tumor treatments. The overall cancer death rate has been falling about 1.5% a year since 1991. It fell 2.2% from 2016 to 2017, according to the...
Read More
June 03, 2019 - 5:12 pm
CHICAGO (AP) — Newer drugs are substantially improving the chances of survival for some people with hard-to-treat forms of lung, breast and prostate cancer, doctors reported at the world's largest cancer conference. Among those who have benefited is Roszell Mack Jr., who at age 87 is still able to...
Read More
FILE- This May 1, 2018, file photo shows Merck corporate headquarters in Kenilworth, N.J. Merck & Co. reports financial results Tuesday, April 30, 2019. (AP Photo/Seth Wenig, File)
April 30, 2019 - 7:50 am
Surging sales of vaccines and the cancer immunotherapy drug Keytruda led to a quadrupling of profit at Merck during the first quarter as it blew past Wall Street expectations. Sales of Keytruda jump 55% to $2.27 billion, about one-quarter of its total revenue. During the quarter, the injected...
Read More
FILE - In this May 25, 2017 file photo, chemotherapy drugs are administered to a patient at a hospital in Chapel Hill, N.C. The U.S. cancer death rate has been falling between 1991 and 2016, and so far there’s little sign the decline is slowing, according to a report released on Tuesday, Jan. 8, 2019. (AP Photo/Gerry Broome)
January 08, 2019 - 4:12 pm
NEW YORK (AP) — The U.S. cancer death rate has hit a milestone: It's been falling for at least 25 years, according to a new report. Lower smoking rates are translating into fewer deaths. Advances in early detection and treatment also are having a positive impact, experts say. But it's not all good...
Read More
June 06, 2018 - 11:53 am
BOSTON (AP) — Boston University is pairing with Johnson & Johnson to help fight lung cancer. School officials announced Wednesday the company will pay for a new lung center at the university where researchers will work to prevent and cure the disease. It's part of a five-year research...
Read More
This 2015 photo made available by Merck shows the drug Keytruda. Research released on Monday, April 16, 2018 suggests that many more lung cancer patients may benefit from treatments that boost the immune system, which have scored some of their biggest wins until now in less common cancer types. Using one of these drugs _ Merck's Keytruda _ with usual chemotherapy extended survival for people newly diagnosed with the most common type of cancer that had spread beyond the lungs, one study found. (Michael Lund/Merck via AP)
April 16, 2018 - 10:42 am
CHICAGO (AP) — For the first time, a treatment that boosts the immune system greatly improved survival in people newly diagnosed with the most common form of lung cancer. It's the biggest win so far for immunotherapy, which has had much of its success until now in less common cancers. In the study...
Read More
Dr. Sunil Singhal, second from right, directs a special camera to view a tumor in his patient made visible with a fluorescent dye, seen at monitor on right, at the Hospital of the University of Pennsylvania in Philadelphia, Tuesday, Jan. 23, 2018. Researchers are testing fluorescent dyes that make cancer cells glow to make them easier for surgeons to find, giving patients a better shot at survival. (AP Photo/Matt Rourke)
March 14, 2018 - 11:29 am
PHILADELPHIA (AP) — It was an ordinary surgery to remove a tumor — until doctors turned off the lights and the patient's chest started to glow. A spot over his heart shined purplish pink. Another shimmered in a lung. They were hidden cancers revealed by fluorescent dye, an advance that soon may...
Read More

Pages